Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Oncotarget|July 30, 2015
Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimeticsGaurav S Choudhary, Trinh T Tat, Saurav Misra, et al.
Nucleic Acids Research|October 3, 2020
CK2 kinase-mediated PHF8 phosphorylation controls TopBP1 stability to regulate DNA replicationHaihua Feng, Jingchen Lu, Xiaotian Song, et al.
Plos One|April 9, 2013
PARP inhibition sensitizes to low dose-rate radiation TMPRSS2-ERG fusion gene-expressing and PTEN-deficient prostate cancer cellsPayel Chatterjee, Gaurav S Choudhary, Arishya Sharma, et al.
British Journal of Haematology|July 30, 2013
The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathwaysJuraj Bodo, Xiaoxian Zhao, Arishya Sharma, et al.
Cell Death & Disease|December 6, 2019
Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignanciesIsha Kapoor, Yue Li, Arishya Sharma, et al.
Cancer Biology & Therapy|July 29, 2004
Effects of resveratrol on gene expression in renal cell carcinomaTing Shi, Louis S Liou, Provash Sadhukhan, et al.
Molecular Cancer Therapeutics|May 31, 2015
The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP InhibitionPayel Chatterjee, Gaurav S Choudhary, Turkeyah Alswillah, et al.
BMC Urology|June 24, 2004
Microarray gene expression profiling and analysis in renal cell carcinomaLouis S Liou, Ting Shi, Zhong-Hui Duan, et al.
Molecular Cancer|March 25, 2014
Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin)Kamini Singh, Arishya Sharma, Maria C Mir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivoNing Zhou, Kamini Singh, Maria C Mir, et al.
Pageof 6